Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...

Viking Therapeutics Inc.’s stock was up up as much as 3.8% early Friday as excitement continued to build about data on the ...

A man has been fined more than £1,000 for selling fake weight loss pills. The pills, named Slimbod and found at a retailer in ...

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...

which achieved a 3.3% placebo-adjusted weight loss in participants after 28 days based on a 40-milligram dose. The company's update offered data on the higher dosing arms of 60 mg and 80 mg ...

The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 ...

Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it ...

The company is expected to offer data on the ... and Eli Lilly & Co. (LLY), are working to develop a weight-loss pill. Jefferies is confident Viking's stock still has plenty of upside.